Animal Models for Anorexia Nervosa - A Systematic Review
Sophie Scharner and Andreas Stengel, Front. Hum. Neurosci., 20 January 2021
Recommended by Josefina Castro-Fornieles, Spain: 'Animal models have so far contributed many findings to the understanding of mechanisms of hunger and satiety, physical activity and cognition in an underweight state and other mechanisms relevant for anorexia nervosa in humans. Especially it is encouraged further research on the gut-brain-axis including intestinal microbiome changes and further research in neuronal brain circuit alterations including neurotransmitter changes.'
Short-term metreleptin treatment of patients with anorexia nervosa: rapid on-set of beneficial cognitive, emotional, and behavioral effects
Milos G et al., Translational Psychiatry, 27 August 2020
Recommended by Roger Adan, The Netherlands: 'I am in particular enthusiastic about this study. Now that metreleptin is approved for the treatment of lipodystrophy a window of opportunity was created to test this drug in anorexia nervosa patients. In an open label study metreleptin improved mood and cognition over days following initiation of treatment. This is a potential game changer for a disease where no pharmacotherapy is available.'